Russia’s antimonopoly service initiates iPhone7 price audit — regulatorBusiness & Economy October 24, 15:03
Sharapova will be back in WTA rankings after 3 tournaments next year — officialSport October 24, 14:58
Ukraine's self-proclaimed republics against deploying armed OSCE mission to DonbassWorld October 24, 14:39
Rusnano says it has no business ties with Clinton’s campaign chairmanBusiness & Economy October 24, 14:33
Minister says Russia’s information systems reliably protected from cyberattacksRussian Politics & Diplomacy October 24, 14:31
Kremlin gives no comment on alleged attack on Foreign Ministry’s websiteRussian Politics & Diplomacy October 24, 14:14
Kremlin says has no idea of protest potential assessment program at Russian universitiesSociety & Culture October 24, 14:09
Russian, Egyptian paratroops practice operation to storm "militants-held" villageMilitary & Defense October 24, 14:07
Ukraine lodges protest against Syria’s recognition of CrimeaWorld October 24, 13:49
ST. PETERSBURG, December 29. /TASS/. A group of scientists at the St. Petersburg-based Research Institute of Influenza have developed a vaccine against the deadly Ebola virus and its trials are due to complete in Africa in February, the director of the institute said on Monday.
“The candidate vaccine against Ebola created by a group of young scientists of our institute is undergoing tests for genetic stability,” Oleg Kiselev said, adding that the vaccine will be called “candidate” until its industrial production begins.
The vaccine has been already sent to the Virology Center of the Ministry of Defense and will be first tested on animals. The clinical tests involving volunteers will be conducted in Africa.
All the stages of trials are due to wrap up in February, Kiselev said.
The latest figures by the World Health Organization (WHO) show that the death toll from the current Ebola outbreak has reached 7,693 and as many as 19,695 have been infected. Most deaths were reported in the hardest-hit West African countries — Liberia, Sierra Leone and Guinea.